Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 21, 2014; 20(43): 16293-16299
Published online Nov 21, 2014. doi: 10.3748/wjg.v20.i43.16293
Published online Nov 21, 2014. doi: 10.3748/wjg.v20.i43.16293
ROME III cohort | |||||
AN-R (n = 27) | AN-P (n = 20) | BN (n = 9) | EDNOS-R (n = 14) | EDNOS-P (n = 30) | |
A: Functional Esophageal Disorders | 14.8% | 35.0% | 33.3% | 42.9% | 46.7% |
B: Functional Gastroduodenal Disorders | 44.4% | 75.0% | 88.9% | 42.9% | 70.0% |
Without cyclic vomiting | 44.4% | 60.0% | 44.4% | 35.7% | 40.0% |
C: Functional Bowel Disorders | 63.0% | 85.0% | 77.8% | 85.7% | 80.0% |
Without unspecified bowel disease | 40.7% | 65.0% | 55.6% | 50.0% | 56.7% |
D: Functional Abdominal Pain Syndrome | 7.4% | 5.0% | 0.0% | 0.0% | 0.0% |
E: Functional Anorectal Disorders1 | 7.4% | 10.0% | 11.1% | 35.7% | 20.0% |
Total | |||||
At least one FGID | 70.4% | 95.0% | 88.9% | 85.7% | 83.3% |
At least 3 FGIDs | 18.5% | 40.0% | 33.3% | 35.7% | 43.3% |
- Citation: Wang X, Luscombe GM, Boyd C, Kellow J, Abraham S. Functional gastrointestinal disorders in eating disorder patients: Altered distribution and predictors using ROME III compared to ROME II criteria. World J Gastroenterol 2014; 20(43): 16293-16299
- URL: https://www.wjgnet.com/1007-9327/full/v20/i43/16293.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i43.16293